HemOnc Today New York

The latest news from the annual meeting, including video perspective from faculty members and attendees.


Meeting News Coverage

Adjuvant therapy remains important option for high-risk melanoma patients

April 30, 2012
NEW YORK — Adjuvant therapy remains an important treatment option for those who are at high risk for progression to metastatic melanoma…
Meeting News Coverage

More clinical trials will better define imiquimod’s role in lentigo maligna

April 26, 2012
NEW YORK — Topical imiquimod can be beneficial in the treatment of lentigo maligna, but questions remain regarding its efficacy, according to a…
Meeting News Coverage

Targeted therapies becoming a treatment option for advanced basal cell carcinoma

HemOnc Today, July 25, 2011
NEW YORK — Most basal cell carcinomas are treatable with local therapy but for locally advanced or metastatic disease, new targeted…
Meeting News CoverageMeeting News Coverage

Immune response predicts improved survival in Merkel cell carcinoma

HemOnc Today, July 25, 2011
HEMONC TODAY Melanoma and Cutaneous Malignancies. NEW YORK — Merkel cell carcinoma is a relatively rare cancer, with 1,600 new cases per year in…
Meeting News CoverageMeeting News Coverage

Computer-assisted melanoma surveillance may play larger role in clinical practice

HemOnc Today, July 25, 2011
HEMONC TODAY Melanoma and Cutaneous Malignancies. NEW YORK -- Computer-assisted surveillance will be an increasingly important tool in the future…
Meeting News Coverage

NORDIC: No OS benefit with intermediate-dose interferon alfa-2b in melanoma

June 25, 2011
HEMONC TODAY Melanoma and Cutaneous Malignancies. NEW YORK — Phase-3 results from the NORDIC trial showed that there was no survival advantage…
Meeting News Coverage

Studies validate the use of sunscreen, discourage indoor tanning, to lower melanoma risk

June 25, 2011
HEMONC TODAY Melanoma and Cutaneous Malignancies. NEW YORK — New data and a review of recent studies on the use of sunscreen to prevent melanoma…
Meeting News Coverage

In “Year of Melanoma,” meeting offers information, innovation

HemOnc Today, May 25, 2011
The HemOnc Today Melanoma and Cutaneous Malignancies Meeting, being held June 25-26 in New York City, is a unique meeting dedicated specifically…
Meeting News Coverage

Melanoma meeting rounds up a busy year in melanoma research and treatment

HemOnc Today, April 25, 2011
HemOnc Today is proud to announce the Melanoma and Cutaneous Malignancies New York meeting, June 25-26, at the New York Mariott Marquis. This is…
Meeting News Coverage

HemOnc Today introduces new CME meeting, "HemOnc Today Melanoma and Cutaneous Malignancies"

March 16, 2011
HemOnc Today is pleased to introduce a new CME meeting, "HemOnc Today Melanoma and Cutaneous Malignancies." Intended to educate oncologists and…